β-Nicotinamide Mononucleotide (NMN)
I kēia mau lā, aia ka nūhou maikaʻi ma ke kahua o NMN - ma hope o ka loiloi koʻikoʻi e ke komite ʻoihana o ka hui mana mana o ka US Food and Drug Administration (FDA), nā NMN raw material o Shangke Biopharmaceutical (Shanghai) Co., Ltd. e like me "Shangke Bio") ua apono 'ia e ka United States FDA NDI apono 'ia e kona NMN maka mea hiki ke officially hoʻohana 'ia i loko o ka hana, kuai a me ka paipai 'ana i ka meaʻai kumukanawai a i loko o ka United States, a hiki ke loaʻa ma ka FDA luna. pūnaewele ma ke ʻano he mea hoʻohui meaʻai hou, helu 1247.
ʻO FDA NDI ka ʻōnaehana hōʻoia koʻikoʻi ma ka mākeke US.ʻO ka loaʻa ʻana o kēia palapala hōʻoia ʻaʻole wale ke ʻano o ka palekana a me ka maikaʻi o nā huahana a Shangke Bioʻike nui ʻia, akā kūpono hoʻi i ka hoʻomohala mau ʻana o ka ʻoihana NMN i ka wā lōʻihi.
Inoa Kimia | β-Nicotinamide Mononucleotide |
Nā huaʻōlelo like | NICOTINAMIDE-1-IUM-1-BETA-D-RIBOFURANOSIDE 5'-PHOSPHATE |
Helu CAS | 1094-61-7 |
Kaumaha Molekala | 334.22 |
ʻĀpana Molekala | C11H15N2O8P |
EINECS号: | 214-136-5 |
Lae hehee | 166 °C(Dek.) |
ka mahana mālama. | -20°C |
hikiwawe | DMSO (Lili'ili, Wela), Methanol (Lili'ili), Wai (Liliili) |
ʻano | Paʻa |
kala kala | Keʻokeʻo i Melemele |
ʻO Merck | 13,6697 |
BRN | 3570187 |
Paʻa: | Hygroscopic loa |
InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
Mea hoao | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a keʻokeʻo keʻokeʻo crystalline pauda |
ʻO ka paona | ≤1% |
Waiwai pH (100mg/ml) | 2.0~4.0 |
Maemae | ≥99.0% |
ʻAno wai | ≤1% |
Nā metala kaumaha | <10ppm |
Arsenic | <0.5ppm |
Ke alakaʻi | <0.5ppm |
Mercury | <0.1ppm |
Cadmium | <0.5ppm |
Ke koena solvent | Ethanol≤1000ppm |
Huina Aerobic Microbial Helu | <750cfu/g |
Huna & Mold | <25cfu/g |
huina coliform | ≤0.92MPN/g |
E. Coli | ʻinoʻino |
Salmonella | ʻinoʻino |
ʻO Staph.ʻAureus | ʻinoʻino |
ʻIke (ma ke kumu anhydrous) | ≥99.0% |
Laki kānana | ≥95% |
ʻAno nui | Hōʻike no ka ʻike |
Pūʻolo:ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu paʻa māmā, no ka mālama lōʻihi e mālama ʻia ma 2~8°C a i lalo.
ʻO Nicotinamide Mononucleotide (NMN) kahi mana hou o ka huaʻa B3 he 1 ka pae mua i ka NAD + (Nicotinamide Adenine Dinucleotide).ʻO NMN ka mea hoʻihoʻi cellular NAD + mua i hōʻoia ʻia e hoʻihoʻi i nā cell i vivo.
ʻO Nicotinamide Adenine Dinucleotide (NAD) kekahi o nā mea nui a hoihoi i loko o ke kino.Pono ia ma luna o 500 enzymatic reactions a pāʻani i nā kuleana koʻikoʻi i ka hoʻoponopono ʻana i nā kaʻina hana koʻikoʻi nui (Ansari a me Raghava, 2010).Ma luna o nā mea a pau, hiki iā mākou ke alakaʻi i ke ola olakino a lōʻihi.
Loaʻa ka Nicotinamide Adenine Dinucleotide (NAD) ma kāna ʻano oxidized (NAD+) a i ʻole ʻano hoʻemi ʻia (NADH), ʻo ia nā cofactors koʻikoʻi o kekahi mau oxireductases.
ʻO SyncoZyems ka mea mua i loaʻa i ka FDA NDI NMN i ʻae ʻia i ka ʻoihana hana waiwai maka, e hōʻike ana i ka luna FDA e ʻae iā NMN ma ke ʻano he ʻano mea hou hiki ke hoʻomaka e ʻae ʻia a ʻae ʻia no nā mea hoʻohui meaʻai ma ʻAmelika Hui Pū ʻIa.